Concepedia

Donna Oksenberg

DO

Statistics

Publications

41

Citations

2.7K

H-Index

25

Active since

1988

Affiliations

Global Blood Therapeutics (United States)(Current)

Stanford University

Rapt Therapeutics (United States)

University of California San Diego

Springhouse

Donna Oksenberg is an author at Global Blood Therapeutics (United States) specializing in pharmacology, medicine, and life sciences.

Publications per year

1988–2023

41

Publications

41

A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptors

Donna Oksenberg, Scot A. Marsters, Brian F. O’Dowd et al. · Nature · 1992 · 279 citations

, , +12

<scp>GBT</scp>440 increases haemoglobin oxygen affinity, reduces sickling and prolongs <scp>RBC</scp> half‐life in a murine model of sickle cell disease

Donna Oksenberg, Kobina Dufu, Mira Patel et al. · British Journal of Haematology · 2016 · 235 citations · Full text

, , +17

Discovery of GBT440, an Orally Bioavailable R-State Stabilizer of Sickle Cell Hemoglobin

Brian Metcalf, Chih-Yuan Chuang, Kobina Dufu et al. · ACS Medicinal Chemistry Letters · 2017 · 190 citations · Full text

, , +17

Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor

Patricia Andrade‐Gordon, Bruce E. Maryanoff, Claudia K. Derian et al. · Proceedings of the National Academy of Sciences · 1999 · 187 citations

, , +17

Characterization of the human 5-hydroxytryptamine1B receptor.

Hui Jin, Donna Oksenberg, Avi Ashkenazi et al. · Journal of Biological Chemistry · 1992 · 177 citations · Full text

, , +17

1–5 of 41